A shrinking piece of the pie to fund new medicines

July 26, 2019 Latest News

This is a preview of subscriber content

Subscribe now to continue reading.

The government, and specifically health minister Greg Hunt, do not have over $9 billion in net PBS spending to offset the cost of new listings - they effectively have somewhere between just $4 and $5 billion. …

Subscribe now to continue reading.

Latest Video

Georgia Forrest

Pfizer calls for Budget shift, citing missed medicines and the impact of lost productivity
February 1, 2026 - Latest News
Another potential turning point for immunotherapy access in Australia
February 1, 2026 - Latest News
Vertex announces PBS listing of new once-daily treatment for cystic fibrosis
February 1, 2026 - Latest News
Better Access Australia’s plan to make care fair, affordable and accountable
February 1, 2026 - Latest News
An announcement that cost more than the listing, because it would have actually cost something
February 1, 2026 - Latest News

A shrinking piece of the pie to fund new medicines

This is a preview of subscriber content

Latest Video

Most Read

Pfizer calls for Budget shift, citing missed medicines and the impact of lost productivity

Another potential turning point for immunotherapy access in Australia

Vertex announces PBS listing of new once-daily treatment for cystic fibrosis

Better Access Australia’s plan to make care fair, affordable and accountable

An announcement that cost more than the listing, because it would have actually cost something

New Stories

AusBiotech urges adoption national life sciences strategy as global competition intensifies

Cyclopharm delivers record revenue as US emerges as growth engine

Sandoz adds to vision care options with the listing of biosimilar aflibercept

PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history

Genetic Signatures appoints seasoned life sciences executive as CEO

EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe

Recce Pharmaceuticals deepens US partnership to advance burn wound treatment

Sign In

A shrinking piece of the pie to fund new medicines

This is a preview of subscriber content

Latest Video

Most Read

Pfizer calls for Budget shift, citing missed medicines and the impact of lost productivity

Another potential turning point for immunotherapy access in Australia

Vertex announces PBS listing of new once-daily treatment for cystic fibrosis

Better Access Australia’s plan to make care fair, affordable and accountable

An announcement that cost more than the listing, because it would have actually cost something

Follow Us

New Stories

AusBiotech urges adoption national life sciences strategy as global competition intensifies

Cyclopharm delivers record revenue as US emerges as growth engine

Sandoz adds to vision care options with the listing of biosimilar aflibercept

PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history

Genetic Signatures appoints seasoned life sciences executive as CEO

EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe

Recce Pharmaceuticals deepens US partnership to advance burn wound treatment